15 March 2005 | Volume 142 Issue 6 | Pages 393-402
Background: Clinical trials indicate that a sizable proportion of adults have multiple borderline coronary risk factors and may benefit from treatment.
Objective: To estimate the relative and absolute contributions of borderline and elevated risk factors to the population burden of coronary heart disease (CHD) events.
Design: A prospective cohort study and a national cross-sectional survey.
Setting: The Framingham Study and the Third National Health and Nutrition Examination Survey (NHANES III).
Participants: White non-Hispanic persons in the Framingham Study and in NHANES III who were between 35 to 74 years of age and had no CHD.
Measurements: Occurrence of first CHD events according to 5 major CHD risk factors: blood pressure, low-density lipoprotein and high-density lipoprotein cholesterol levels, glucose intolerance, and smoking. Three categoriesoptimal, borderline, and elevatedwere defined for each risk factor per national guidelines. Sex-specific 10-year CHD event rates from the Framingham Study were applied to numbers of at-risk individuals estimated from NHANES III and the 2000 U.S. Census.
Results: Twenty-six percent of men and 41% of women had at least 1 borderline risk factor in NHANES III. According to estimates, more than 90% of CHD events will occur in individuals with at least 1 elevated risk factor, and approximately 8% will occur in people with only borderline levels of multiple risk factors. Absolute 10-year CHD risk exceeded 10% in men older than age 45 years who had 1 elevated risk factor and 4 or more borderline risk factors and in those who had at least 2 elevated risk factors. In women, absolute CHD risk exceeded 10% only in those older than age 55 years who had at least 3 elevated risk factors.
Limitations: The generalizability of the findings to persons of other ethnic backgrounds is unknown.
Conclusions: Borderline CHD risk factors alone account for a small proportion of CHD events.
Editors' Notes
Context
Contribution
Implications
The Editors
Author and Article Information
From the Framingham Heart Study, Framingham, Massachusetts; Medical University of South Carolina, Charleston, South Carolina; State University of New York at Buffalo, Buffalo, New York; National Heart, Lung, and Blood Institute, Bethesda, Maryland; and Boston University, Boston, Massachusetts.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Ramachandran S. Vasan, MD, Framingham Heart Study, 73 Mount Wayte Avenue, Suite 2, Framingham, MA 01702-5803; e-mail, vasan{at}bu.edu.
Current Author Addresses: Drs. Vasan, Kannel, and Levy: Framingham Heart Study, 73 Mount Wayte Avenue, Suite 2, Framingham, MA 01702-5803.
Drs. Sullivan and D'Agostino: Boston University Statistics and Consulting Unit, 704 Commonwealth Avenue, 5th Floor, Boston, MA 02215.
Dr. Wilson: Department of Endocrinology, Diabetes, and Medical Genetics, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 215, Charleston, SC 29425.
Dr. Sempos: Department of Social & Preventive Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14214.
Dr. Sundström: Department of Public Health & Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden.
Author Contributions: Conception and design: R.S. Vasan, L.M. Sullivan, P.W.F. Wilson, J. Sundström, W.B. Kannel, D. Levy, R.B. D'Agostino.
Analysis and interpretation of the data: R.S. Vasan, L.M. Sullivan, P.W.F. Wilson, C.T. Sempos, J. Sundström, W.B. Kannel, D. Levy, R.B. D'Agostino.
Drafting of the article: R.S. Vasan, L.M. Sullivan, J. Sundström, W.B. Kannel, D. Levy, R.B. D'Agostino.
Critical revision of the article for important intellectual content: R.S. Vasan, P.W.F. Wilson, C.T. Sempos, J. Sundström, W.B. Kannel, D. Levy.
Final approval of the article: R.S. Vasan, L.M. Sullivan, P.W.F. Wilson, C.T. Sempos, J. Sundström, W.B. Kannel, D. Levy, R.B. D'Agostino.
Provision of study materials or patients: P.W.F. Wilson, D. Levy, R.B. D'Agostino.
Statistical expertise: L.M. Sullivan, R.B. D'Agostino.
Obtaining of funding: R.S. Vasan, R.B. D'Agostino.
Administrative, technical, or logistic support: P.W.F. Wilson, D. Levy, R.B. D'Agostino.
Collection and assembly of data: P.W.F. Wilson, D. Levy, R.B. D'Agostino. ARTICLE
Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors
![]()
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
J. N. Cohn and D. A. Duprez Time to Foster a Rational Approach to Preventing Cardiovascular Morbid Events J. Am. Coll. Cardiol., July 29, 2008; 52(5): 327 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W.F. Wilson, S. R. Bozeman, T. M. Burton, D. C. Hoaglin, R. Ben-Joseph, and C. L. Pashos Prediction of First Events of Coronary Heart Disease and Stroke With Consideration of Adiposity Circulation, July 8, 2008; 118(2): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Phillips and J. G. Twombly It's Time to Overcome Clinical Inertia Ann Intern Med, May 20, 2008; 148(10): 783 - 785. [Full Text] [PDF] |
||||
![]() |
B. J. Turner, C. S. Hollenbeak, M. Weiner, T. Ten Have, and S. S.K. Tang Effect of Unrelated Comorbid Conditions on Hypertension Management Ann Intern Med, April 15, 2008; 148(8): 578 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF] |
||||
![]() |
J. C. Geller, S. Cassens, M. Brosz, U. Keil, J. Bernarding, S. Kropf, R. A. Bierwirth, B. Lippmann-Grob, H.-P. Schultheiss, K. Schluter, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study Eur. Heart J., December 2, 2007; 28(24): 3051 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Greenland and D. Lloyd-Jones Time to End the Mixed and Often Incorrect Messages About Prevention and Treatment of Atherosclerotic Cardiovascular Disease J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2133 - 2135. [Full Text] [PDF] |
||||
![]() |
R. S. Beaser and P. Levy A Work in Progress, but a Useful Construct Circulation, April 3, 2007; 115(13): 1812 - 1818. [Full Text] [PDF] |
||||
![]() |
A. Hozawa, A. R. Folsom, A. R. Sharrett, and L. E. Chambless Absolute and Attributable Risks of Cardiovascular Disease Incidence in Relation to Optimal and Borderline Risk Factors: Comparison of African American With White Subjects--Atherosclerosis Risk in Communities Study Arch Intern Med, March 26, 2007; 167(6): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF] |
||||
![]() |
R. A. Hayward, T. P. Hofer, and S. Vijan Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med, October 3, 2006; 145(7): 520 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Hankey Potential New Risk Factors for Ischemic Stroke: What Is Their Potential? Stroke, August 1, 2006; 37(8): 2181 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kahn The Metabolic Syndrome (Emperor) Wears No Clothes Diabetes Care, July 1, 2006; 29(7): 1693 - 1696. [Full Text] [PDF] |
||||
![]() |
T. Thom, N. Haase, W. Rosamond, V. J. Howard, J. Rumsfeld, T. Manolio, Z.-J. Zheng, K. Flegal, C. O'Donnell, S. Kittner, et al. Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 14, 2006; 113(6): e85 - e151. [Full Text] [PDF] |
||||
![]() |
D. Giugliano and K. Esposito The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Kahn et al. Diabetes Care, January 1, 2006; 29(1): 175 - 176. [Full Text] [PDF] |
||||
![]() |
R. Kahn, J. Buse, E. Ferrannini, and M. Stern The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Citrome et al., Giugliano and Esposito, Cheta, and Psaty et al. Diabetes Care, January 1, 2006; 29(1): 177 - 178. [Full Text] [PDF] |
||||
![]() |
M. GLICK and B. L. GREENBERG The potential role of dentists in identifying patients' risk of experiencing coronary heart disease events J Am Dent Assoc, November 1, 2005; 136(11): 1541 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
Borderline Risk Factors Cause Few CHD Events Journal Watch Cardiology, April 22, 2005; 2005(422): 2 - 2. [Full Text] |
||||
![]() |
Correction: Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors Ann Intern Med, April 19, 2005; 142(8): 681 - 681. [Full Text] [PDF] |
||||
![]() |
A. Tonks What's new in the other general journals BMJ, March 26, 2005; 330(7493): 693 - 694. [Full Text] [PDF] |
||||
![]() |
C. Mulrow and W. Kussmaul The Middle-Aged and Older American: Wrong Prototype for a Preventive Polypill? Ann Intern Med, March 15, 2005; 142(6): 467 - 468. [Full Text] [PDF] |
||||
Read all Rapid Responses